178 related articles for article (PubMed ID: 24958459)
1. PPARβ/δ activation of CD300a controls intestinal immunity.
Tanaka T; Tahara-Hanaoka S; Nabekura T; Ikeda K; Jiang S; Tsutsumi S; Inagaki T; Magoori K; Higurashi T; Takahashi H; Tachibana K; Tsurutani Y; Raza S; Anai M; Minami T; Wada Y; Yokote K; Doi T; Hamakubo T; Auwerx J; Gonzalez FJ; Nakajima A; Aburatani H; Naito M; Shibuya A; Kodama T; Sakai J
Sci Rep; 2014 Jun; 4():5412. PubMed ID: 24958459
[TBL] [Abstract][Full Text] [Related]
2. GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR
Lu W; Huang J; Flores J; Li P; Wang W; Liu S; Zhang JH; Tang J
Exp Neurol; 2024 Feb; 372():114615. PubMed ID: 37995951
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-β/δ modulates mast cell phenotype.
Yao PL; Morales JL; Gonzalez FJ; Peters JM
Immunology; 2017 Apr; 150(4):456-467. PubMed ID: 27935639
[TBL] [Abstract][Full Text] [Related]
4. CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines.
Kim EJ; Lee SM; Suk K; Lee WH
Immunology; 2012 Mar; 135(3):226-35. PubMed ID: 22043923
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain.
Yu S; Levi L; Casadesus G; Kunos G; Noy N
J Biol Chem; 2014 May; 289(18):12748-58. PubMed ID: 24644281
[TBL] [Abstract][Full Text] [Related]
6. Endothelial, but not smooth muscle, peroxisome proliferator-activated receptor β/δ regulates vascular permeability and anaphylaxis.
Wawrzyniak M; Pich C; Gross B; Schütz F; Fleury S; Quemener S; Sgandurra M; Bouchaert E; Moret C; Mury L; Rommens C; Mottaz H; Dombrowicz D; Michalik L
J Allergy Clin Immunol; 2015 Jun; 135(6):1625-35.e5. PubMed ID: 25556996
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
[TBL] [Abstract][Full Text] [Related]
8. β-Sitosterol attenuates high-fat diet-induced intestinal inflammation in mice by inhibiting the binding of lipopolysaccharide to toll-like receptor 4 in the NF-κB pathway.
Kim KA; Lee IA; Gu W; Hyam SR; Kim DH
Mol Nutr Food Res; 2014 May; 58(5):963-72. PubMed ID: 24402767
[TBL] [Abstract][Full Text] [Related]
9. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor.
Nakahashi-Oda C; Tahara-Hanaoka S; Shoji M; Okoshi Y; Nakano-Yokomizo T; Ohkohchi N; Yasui T; Kikutani H; Honda S; Shibuya K; Nagata S; Shibuya A
J Exp Med; 2012 Jul; 209(8):1493-503. PubMed ID: 22826299
[TBL] [Abstract][Full Text] [Related]
11. Nonhemopoietic cell TLR4 signaling is critical in causing early lipopolysaccharide-induced ileus.
Buchholz BM; Chanthaphavong RS; Bauer AJ
J Immunol; 2009 Nov; 183(10):6744-53. PubMed ID: 19846874
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
13. Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression.
Tan NS; Michalik L; Di-Poï N; Ng CY; Mermod N; Roberts AB; Desvergne B; Wahli W
EMBO J; 2004 Oct; 23(21):4211-21. PubMed ID: 15470497
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment.
Schumann T; Adhikary T; Wortmann A; Finkernagel F; Lieber S; Schnitzer E; Legrand N; Schober Y; Nockher WA; Toth PM; Diederich WE; Nist A; Stiewe T; Wagner U; Reinartz S; Müller-Brüsselbach S; Müller R
Oncotarget; 2015 May; 6(15):13416-33. PubMed ID: 25968567
[TBL] [Abstract][Full Text] [Related]
15. PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.
Zhu B; Ferry CH; Blazanin N; Bility MT; Khozoie C; Kang BH; Glick AB; Gonzalez FJ; Peters JM
Oncogene; 2014 Nov; 33(46):5348-59. PubMed ID: 24213576
[TBL] [Abstract][Full Text] [Related]
16. Identification of phosphatidylserine as a ligand for the CD300a immunoreceptor.
Nakahashi-Oda C; Tahara-Hanaoka S; Honda S; Shibuya K; Shibuya A
Biochem Biophys Res Commun; 2012 Jan; 417(1):646-50. PubMed ID: 22185693
[TBL] [Abstract][Full Text] [Related]
17. The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signaling.
Alvarez Y; Tang X; Coligan JE; Borrego F
Mol Immunol; 2008 Jan; 45(1):253-8. PubMed ID: 17588661
[TBL] [Abstract][Full Text] [Related]
18. Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing.
Chong HC; Tan MJ; Philippe V; Tan SH; Tan CK; Ku CW; Goh YY; Wahli W; Michalik L; Tan NS
J Cell Biol; 2009 Mar; 184(6):817-31. PubMed ID: 19307598
[TBL] [Abstract][Full Text] [Related]
19. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
[TBL] [Abstract][Full Text] [Related]
20. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
